What is it used for?
AUGTYRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) . AUGTYRO is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that: •have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion , •are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and •have progressed following treatment or have no satisfactory alternative therapy. This indication is approved under accelerated approval based on overall response rate and duration of response …AUGTYRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) . AUGTYRO is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that: •have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion , •are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and •have progressed following treatment or have no satisfactory alternative therapy. This indication is approved under accelerated approval based on overall response rate and duration of response …
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- repotrectinibrepotrectinib
- Form and strength
- CAPSULE · 40 mg; CAPSULE · 160 mgCAPSULE · 40 mg; CAPSULE · 160 mg
- Manufacturer / applicant
- E.R. SQUIBB & SONS, L.L.C.E.R. SQUIBB & SONS, L.L.C.
Capsules: 40 mg, white, opaque, immediate release, Size 0, hard shell capsule, filled with white to off-white powder which may appear as a plug, imprinted with “REP 40” in blue text on the cap. Capsules: 160 mg, blue, …Capsules: 40 mg, white, opaque, immediate release, Size 0, hard shell capsule, filled with white to off-white powder which may appear as a plug, imprinted with “REP 40” in blue text on the cap. Capsules: 160 mg, blue, …
Safety and clinical review
- Central Nervous System Adverse ReactionsCentral Nervous System Adverse Reactions
- Interstitial Lung Disease/PneumonitisInterstitial Lung Disease/Pneumonitis
- HepatotoxicityHepatotoxicity
- Myalgia with Creatine Phosphokinase ElevationMyalgia with Creatine Phosphokinase Elevation
- HyperuricemiaHyperuricemia
- Skeletal FracturesSkeletal Fractures
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Augtyro used for?
AUGTYRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) . AUGTYRO is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that: •have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion , •are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and •have progressed following treatment or have no satisfactory alternative therapy. This indication is approved under accelerated approval based on overall response rate and duration of response …AUGTYRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) . AUGTYRO is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that: •have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion , •are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and •have progressed following treatment or have no satisfactory alternative therapy. This indication is approved under accelerated approval based on overall response rate and duration of response …
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Augtyro should I ask about?
CAPSULE · 40 mg; CAPSULE · 160 mgCAPSULE · 40 mg; CAPSULE · 160 mg
Read the primary sourceWhat determines the price of Augtyro?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Augtyro?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.